SMARCB1 and epithelioid sarcoma: The loss of SMARCA4 (BRG-1) can exceptionally occur in tumors such as SMARCB1/INI1-retained epithelioid sarcoma (ES); in this context, the absence of SOX2 and SALL4 expression aids in distinguishing ES from SMARCA4-UT (19).